S3340 The Cryptic Lymphoma

Introduction: Primary Pancreatic lymphoma (PPL) is a rare condition accounting for approximately 1% of all extra nodal lymphomas. It presents as a solitary pancreatic mass and can mimic pancreatic adenocarcinoma, neuroendocrine tumors, or pancreatitis. Most common symptoms include abdominal pain, followed by jaundice, nausea, vomiting, and rarely gastric outlet syndrome. This is a rare case of incidental primary pancreatic lymphoma in a patient who initially presented for perioperative evaluation of inguinal hernia repair. Case Description/Methods: Patient is an 80-year-old man with a past medical history of gastroesophageal reflux disease (GERD), who presented to the surgeon’s office due to concerns of bulge and discomfort in the right inguinal region. He did report worsening of his GERD symptoms but denied nausea, vomiting, epigastric pain, abdominal distension, or change in appetite or bowel habits. A computed tomography scan of abdomen and pelvis was performed as a part of preoperative evaluation of elective inguinal hernia repair which revealed a mass lesion measuring up to 8.0 × 4.2 × 7.4 cm inferior to the head of the pancreas with significant mass effect invading the third portion of the duodenum and encasement of the superior mesenteric vessels. Following computed tomography imaging, the patient subsequently developed nausea and vomiting after a few days. Tumor markers, including Alpha fetoprotein, CA-19-9, and Carcinoembryonic antigen (CEA) were within normal limits. Endoscopic ultrasound biopsy was performed, which revealed large B-cell lymphoma consistent with PPL. The patient was initiated on Rituximab, Gemcitabine, cyclophosphamide, vincristine, and prednisone. After 3 cycles of treatment, a complete metabolic response to treatment was observed on a PET scan. Discussion: This case highlights an initially latent but rapidly progressive presentation of PPL. The presentation is unique as the patient did not present with the commonly reported manifestations of PPL, which include epigastric pain, jaundice, and weight loss, but only experienced vague symptoms of reflux. Also, worsening of existing gastroesophageal reflux disease symptoms requires further imaging and should not be ignored. It also highlights the inclusion of PPL as a differential diagnosis in the evaluation of a pancreatic mass.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001140820.71189.9c
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S3340 The Cryptic Lymphoma

Carlos Valladares, Shubhangi Sharma, Song Peng Ang, Shreya Shambhavi
The American Journal of Gastroenterology
Chronic Lymphocytic Leukemia Research
article

S3340 The Cryptic Lymphoma

Carlos Valladares, Shubhangi Sharma, Song Peng Ang, Shreya Shambhavi
article en

Abstract

Introduction: Primary Pancreatic lymphoma (PPL) is a rare condition accounting for approximately 1% of all extra nodal lymphomas. It presents as a solitary pancreatic mass and can mimic pancreatic adenocarcinoma, neuroendocrine tumors, or pancreatitis. Most common symptoms include abdominal pain, followed by jaundice, nausea, vomiting, and rarely gastric outlet syndrome. This is a rare case of incidental primary pancreatic lymphoma in a patient who initially presented for perioperative evaluation of inguinal hernia repair. Case Description/Methods: Patient is an 80-year-old man with a past medical history of gastroesophageal reflux disease (GERD), who presented to the surgeon’s office due to concerns of bulge and discomfort in the right inguinal region. He did report worsening of his GERD symptoms but denied nausea, vomiting, epigastric pain, abdominal distension, or change in appetite or bowel habits. A computed tomography scan of abdomen and pelvis was performed as a part of preoperative evaluation of elective inguinal hernia repair which revealed a mass lesion measuring up to 8.0 × 4.2 × 7.4 cm inferior to the head of the pancreas with significant mass effect invading the third portion of the duodenum and encasement of the superior mesenteric vessels. Following computed tomography imaging, the patient subsequently developed nausea and vomiting after a few days. Tumor markers, including Alpha fetoprotein, CA-19-9, and Carcinoembryonic antigen (CEA) were within normal limits. Endoscopic ultrasound biopsy was performed, which revealed large B-cell lymphoma consistent with PPL. The patient was initiated on Rituximab, Gemcitabine, cyclophosphamide, vincristine, and prednisone. After 3 cycles of treatment, a complete metabolic response to treatment was observed on a PET scan. Discussion: This case highlights an initially latent but rapidly progressive presentation of PPL. The presentation is unique as the patient did not present with the commonly reported manifestations of PPL, which include epigastric pain, jaundice, and weight loss, but only experienced vague symptoms of reflux. Also, worsening of existing gastroesophageal reflux disease symptoms requires further imaging and should not be ignored. It also highlights the inclusion of PPL as a differential diagnosis in the evaluation of a pancreatic mass.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 58%
Chronic Lymphocytic Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.